Owner Allergan, Inc.

Inventors Garst, Michael E.; Gil, Daniel W.; Fang, Wenkui K.; Corpuz, Evelyn G.; Chow, Ken

Agent Davies Collison Cave

Pub. Number AU-A-2007253949

PCT Pub. Number WO2007/137029

Priority 60/747,444 17.05.06 US

Filing date 15 May 2007

Wipo publication date 29 November 2007

C07C 275/24 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 213/40 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 307/52 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom